Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maor Lahav

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Gastroenterology|October 13, 2006
Immunologic basis for diarrheaMaor Lahav, Eugene Chang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Nonsurgical management of asymptomatic incidental pancreatic cystsMaor Lahav, Yakov Maor, Benjamin Avidan, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Clinical and demographic characterization of Jewish Crohn's disease patients in IsraelHerma H Fidder, Benjamin Avidan, Maor Lahav, et al.
The Israel Medical Association Journal : IMAJ|November 7, 2009
Double balloon enteroscopy: a 2 year experienceAdi Lahat, Moshe Nadler, Carlos Simon, et al.
Journal of Clinical Gastroenterology|April 7, 2007
The utility of capsule endoscopy in the diagnosis of Crohn's disease based on patient's symptomsHerma H Fidder, Moshe Nadler, Adi Lahat, et al.
Gastroenterology|December 7, 2007
Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammationShien Hu, Mae J Ciancio, Maor Lahav, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 24, 2004
Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cellsAlon Lang, Maor Lahav, Emad Sakhnini, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Oncotarget|May 27, 2015
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patientsTalia Golan, Elina Zorde Khvalevsky, Ayala Hubert, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Gastroenterology|October 13, 2006
Immunologic basis for diarrheaMaor Lahav, Eugene Chang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Nonsurgical management of asymptomatic incidental pancreatic cystsMaor Lahav, Yakov Maor, Benjamin Avidan, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Clinical and demographic characterization of Jewish Crohn's disease patients in IsraelHerma H Fidder, Benjamin Avidan, Maor Lahav, et al.
The Israel Medical Association Journal : IMAJ|November 7, 2009
Double balloon enteroscopy: a 2 year experienceAdi Lahat, Moshe Nadler, Carlos Simon, et al.
Journal of Clinical Gastroenterology|April 7, 2007
The utility of capsule endoscopy in the diagnosis of Crohn's disease based on patient's symptomsHerma H Fidder, Moshe Nadler, Adi Lahat, et al.
Gastroenterology|December 7, 2007
Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammationShien Hu, Mae J Ciancio, Maor Lahav, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 24, 2004
Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cellsAlon Lang, Maor Lahav, Emad Sakhnini, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Oncotarget|May 27, 2015
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patientsTalia Golan, Elina Zorde Khvalevsky, Ayala Hubert, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Pageof 2